Back to Health News

Major Shift in Cervical Cancer Screening: HPV Tests to Replace Traditional Pap Smears, Self-Collection Now an Option for Women 30+

For the first time, federal guidance recommends that women ages 30 to 65 prioritize HPV testing over traditional Pap smears, with a self-collection option available. HPV tests detect precancerous changes earlier and more accurately than Pap tests, and self-collection could improve screening access.

Major Shift in Cervical Cancer Screening: HPV Tests to Replace Traditional Pap Smears, Self-Collection Now an Option for Women 30+

A Major Policy Shift in Cervical Cancer Screening

For the first time, federal guidance is poised to steer women ages 30 to 65 toward an HPV test rather than the traditional Pap smear. Women can also opt for a self-administered HPV test—a major change from the U.S. Preventive Services Task Force that could affect how millions of women are screened for cervical cancer.

The recommendation, which isn't yet final, came after panel members voted behind closed doors at the conclusion of a two-day meeting, according to a person familiar with the vote who spoke on condition of anonymity.

Why HPV Testing Outperforms Pap Smears

Cervical cancer is one of the most preventable cancers, although recent research suggests the United States is backsliding in efforts to detect the disease early. Human papillomavirus (HPV), the virus behind virtually all cervical cancers, is the most common sexually transmitted infection.

A Pap test looks for abnormal or precancerous cells on the cervix, while an HPV test looks for high-risk strains of the virus—often visible before cell abnormalities develop—allowing women to go longer between tests.

  • A 2018 study published in the Journal of the American Medical Association, including more than 19,000 women, found that HPV tests detect precancerous changes earlier and more accurately than Pap tests.
  • Dr. Sangini Sheth, an associate professor of obstetrics, gynecology and reproductive sciences at Yale School of Medicine, said the Pap test alone misses roughly 50% to 70% of abnormalities, and women who skip HPV tests are far more likely to have an HPV-related problem go undetected.
  • Robert Smith, a cancer epidemiologist with the American Cancer Society, said HPV testing is superior, and self-collected specimens have equivalent accuracy to physician-collected ones.

Self-Collection: More Comfortable and Accessible

Self-collected HPV tests use a simple vaginal swab rather than a speculum, making them generally more comfortable. Sheth noted that self-collection is great for people who have a hard time tolerating a speculum exam and broadens the ability to offer screening through mobile health clinics, freestanding labs, or medical specialty offices where pelvic exams aren't traditionally done.

"We expect [the self-collecting test] to increase screening," Smith added. Some women put off Pap tests because they're uncomfortable or find the exam invasive, especially when performed by a male doctor.

Screening Recommendations by Age

  • Ages 21–29: The task force continues to recommend a Pap test every three years.
  • Ages 30–65: HPV testing is now favored (previously, women could choose among a Pap test every three years, an HPV test every five years, or both every five years).
  • Ages 65+: Screening should stop only if women have had several negative results in a row over the past decade; otherwise, they should keep getting screened.

Insurance Coverage and Policy Outlook

Under the Affordable Care Act, most private insurers generally must cover services the panel recommends at no cost to patients. Task force recommendations are typically final once published, though it's unclear when that will happen. It's also unclear whether Health Secretary Robert F. Kennedy Jr. will need to sign off or seek changes after the Supreme Court ruled last year that he has authority over the panel, including the power to remove members and review recommendations.

In September, Kennedy reshaped the panel, naming eight new members, some of whom own stock in companies that make drugs and other products affected by the group's decisions, according to documents reviewed by The New York Times. Thursday's meeting was the committee's first in more than a year.

A spokesperson for the American College of Obstetricians and Gynecologists said the group is "monitoring the USPSTF process to amend cervical cancer screening recommendations and will evaluate the final proposed changes when available."

The American Cancer Society began prioritizing HPV testing in 2020, though differences remain: it recommends starting screening at 25 with the HPV test, while the task force recommends starting at 21 with Pap tests and switching to HPV testing at 30. For self-collection, the cancer society recommends testing every three years rather than five, pending more long-term data.

The Xiaoshu Health App can sync with Apple Health to track relevant metrics and help you better manage your personal health data.